Paul S. Herendeen

2016 - Valeant Pharmaceuticals International

In 2016, Paul S. Herendeen earned a total compensation of $31.4M as Executive Vice President and Chief Financial Officer at Valeant Pharmaceuticals International.

Compensation breakdown

Bonus$10,400,000
Option Awards$15,937,869
Salary$346,154
Stock Awards$4,690,500
Total$31,374,523

Herendeen received $15.9M in option awards, accounting for 50.80% of the total pay in 2016.

Herendeen also received $10.4M in bonus, $346.2K in salary and $4.7M in stock awards.

Overall ranking

Ranking

40

out of 14,053
Percentile100th

Paul S. Herendeen's 2016 compensation ranked 40th out of 14,053 executive pay records tracked by us this year.

Herendeen earned more than 99.7% of all executives tracked by us in 2016.

Ranking in industry group

Industry groupDrugs
Ranking

3

out of 1,505
Percentile100th

In the industry group of Drugs, Herendeen's pay ranked 3rd out of 1,505 executive pay records tracked by us in 2016.

Herendeen earned more than 99.8% of executives in this group.

Source: SEC filing on March 21, 2018.

Herendeen's colleagues

We found two more compensation records of executives who worked with Paul S. Herendeen at Valeant Pharmaceuticals International in 2016.

2016

Joseph Papa

Valeant Pharmaceuticals International

Chief Executive Officer

2016

Christina Ackermann

Valeant Pharmaceuticals International

General Counsel

News

In-depth

You may also like